Mirae Asset Global Investments Co., Ltd. Repligen Corp Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Repligen Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,281 shares of RGEN stock, worth $174,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,281Holding current value
$174,715% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$691 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$629 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$237 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$194 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.57B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....